Apyx Medical Corp. (NASDAQ: APYX) reported Q1 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $11.18 million.

GUIDANCE:

Apyx Medical Corp. sees FY2022 revenue of $52.5-59 million, versus the consensus of $55.07 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.